CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Websiteglsv-vc.com
Phone+49 (0)89 - 288 151-0
Emailmailbox@glsv-vc.com
Employees
Descriptionventure capital fund

Funds

Offices

HQ
Maximilianstr. 35 C
Munchen, D - 80539, DEU

Tags

Global Life Science Ventures

Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund may also invest in selected later stage companies, including buy-outs. For this purpose, GLSV provides finance, advice and access to expertise and networks. The group currently advises and manages funds totalling more than € 200 million. With offices in Germany and Switzerland, GLSV acts as one team with a global perspective.

Recent Milestones

Investments

Company Date Round Size Participants
Santaris Pharma 6/12Venture Round$12M6
Action Pharma 7/10Series C$6.3M4
Coapt Systems 12/09Debt$3.72M8
Agendia 9/09Series E$23M4
Agendia 8/07Series D$34M3
Coapt Systems 3/07Series E$22.6M7
PIERIS Proteolab 11/06Series B$6.39M5

Videos

Sources

  1. Denmark's Santaris Grabs $12M From Insiders for Clinical Trials (pevc.dowjones.com) [edit]
  2. Action Pharma, A/S: Series C $6.3M (onbiovc.com) [edit]
  3. Coapt Systems takes $3.7M for facial rejuvenation (deals.venturebeat.com) [edit]
  4. Agendia closes $23M Series E financing (fiercebiotech.com) [edit]
  5. Agendia BV raises $34M and Receives Second FDA Clearance (agendia.com) [edit]
  6. Coapt Systems, maker of aesthetic surgery implants, raises $22.6M more (deals.venturebeat.com) [edit]
  7. EDGAR [edit]
Edit This Page
Last Edited 4/30/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy